IL22 and colitis: These results show the role of CARD9 and its effector IL-22 in mediating recovery from colitis in both microbiota-independent and microbiota-dependent manners and highlight the importance of the weaning reaction occurring between the immune system and microbiota for host metabolism and immune functions throughout life.